Quenched activity-based probe imaging beneficial in NMSC

January 30, 2017

(HealthDay)—Quenched activity-based probe imaging can discriminate cancer from normal appearing skin tissue, according to a study published in the February issue of the Journal of the American Academy of Dermatology.

Ethan Walker, M.D., Ph.D., from Case Western Reserve University in Cleveland, and colleagues examined the use of quenched activity-based probe imaging to discriminate cancerous versus normal-appearing . They applied the quenched activity-based probe GB119 to non-melanoma skin cancers (NMSCs) excised from 68 patients. Activation of the probe was validated for hematoxylin-eosin-confirmed cancerous tissue versus normal-appearing skin tissue.

The researchers found that the overall estimated sensitivity and specificity were 0.989 (95 percent confidence interval, 0.940 to 1.00) and 0.894 (95 percent confidence interval, 0.769 to 0.965), respectively, for differentiation of and from normal-appearing skin with topical application of the probe. Compared with conventional hematoxylin-eosin-based pathology, probe activation accurately defined peripheral margins of NMSC.

"These findings merit further studies to determine whether quenched activity-based technology may enable cost-effective increased cure rates for patients with NMSC by reducing re-excision and recurrence rates with a rapid and easily interpretable technological advance," the authors write.

Several authors disclosed financial ties to Akrotome Imaging.

Explore further: Skin cancer incidence up after pancreas transplantation

More information: Full Text (subscription or payment may be required)

Related Stories

Skin cancer incidence up after pancreas transplantation

September 21, 2012
(HealthDay)—Nonmelanoma skin cancers (NMSCs) commonly occur after pancreas transplantation (PT), particularly in those who have a history of skin cancer, according to a study published in the October issue of the Journal ...

Some sun protection behaviors up with history of NMSC

May 23, 2016
(HealthDay)—Individuals with previous nonmelanoma skin cancer (NMSC) are more likely to engage in certain sun protection behaviors than those without previous NMSC, according to a study published online May 16 in the Journal ...

Potential new tool to aid breast cancer surgery (Update)

November 30, 2016
University of Adelaide researchers have developed an optical fiber probe that distinguishes breast cancer tissue from normal tissue - potentially allowing surgeons to be much more precise when removing breast cancer.

Some RA treatments up second nonmelanoma skin cancer risk

October 29, 2015
(HealthDay)—For patients with rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) with prior nonmelanoma skin cancer (NMSC), the risk of second NMSC varies with different treatments, according to a study published ...

Australia leads world in skin cancer incidence but lacks reporting

March 5, 2015
Research published this week in the Australasian Journal of Dermatology confirms that Australia has the highest incidence of skin cancers in the world but lacks in national reporting of the statistics.

Recommended for you

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

Researchers find 11 genes responsible for the spread of cancer

June 20, 2018
A groundbreaking discovery by University of Alberta researchers has identified previously-unknown therapeutic targets that could be key to preventing the spread of cancer.

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.